Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
49
NMPA:49
Drug Approvals
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20253290
- Approval Date
- Jan 24, 2025
NMPA
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20253291
- Approval Date
- Jan 24, 2025
NMPA
Levocarnitine for Injection
- Product Name
- 注射用左卡尼汀
- Approval Number
- 国药准字H20080198
- Approval Date
- Jul 21, 2023
NMPA
Sodiun Demethylcantharidate for Injection
- Product Name
- 注射用去甲斑蝥酸钠
- Approval Number
- 国药准字H20070196
- Approval Date
- Dec 28, 2022
NMPA
Cefpirome Sulfate for Injection
- Product Name
- 注射用硫酸头孢匹罗
- Approval Number
- 国药准字H20084058
- Approval Date
- Aug 31, 2022
NMPA
Cefodizime Sodium for Injection
- Product Name
- 注射用头孢地嗪钠
- Approval Number
- 国药准字H20123093
- Approval Date
- Mar 8, 2022
NMPA
Cefodizime Sodium for Injection
- Product Name
- 注射用头孢地嗪钠
- Approval Number
- 国药准字H20123066
- Approval Date
- Mar 8, 2022
NMPA
Topotecan Hydrochloride for Injection
- Product Name
- 注射用盐酸托泊替康
- Approval Number
- 国药准字H20113482
- Approval Date
- Nov 30, 2021
NMPA
Topotecan Hydrochloride for Injection
- Product Name
- 注射用盐酸托泊替康
- Approval Number
- 国药准字H20113461
- Approval Date
- Nov 30, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found